Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Nonalcoholic Steatohepatitis (NASH) Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Nov-2018 | Published By : QYResearch | Category : Healthcare | Pages : 125

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Nonalcoholic Steatohepatitis (NASH) Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Nov-2018 | Published By : QYResearch | Category : Healthcare | Pages : 125 | Format : PDF

This report studies the global Nonalcoholic Steatohepatitis (NASH) market status and forecast, categorizes the global Nonalcoholic Steatohepatitis (NASH) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report 
    Boehringer Ingelheim
    Cerenis Therapeutics
    Connexios Life Sciences
    Genfit
    Islet Sciences
    Nimbus Therapeutics
    Verva Pharmaceuticals
    Viking Therapeutics
    Astazeneca Plc
    Galmed Pharmaceuticals
    GENFIT SA
    Gilead Science
    Novo Nordisk
    Immuron
    Intercepts Pharmaceuticals
    Enzo Biochem
    Tobira Therapeutics

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Weight Loss Treatment
    Insulin-Sensitizing Agents
    Lipid-Lowering Drugs
    Antioxidants
    Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Clinics
    Research Institute
    Other

The study objectives of this report are:
    To analyze and study the global Nonalcoholic Steatohepatitis (NASH) capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Nonalcoholic Steatohepatitis (NASH) manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nonalcoholic Steatohepatitis (NASH) are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nonalcoholic Steatohepatitis (NASH) Manufacturers
Nonalcoholic Steatohepatitis (NASH) Distributors/Traders/Wholesalers
Nonalcoholic Steatohepatitis (NASH) Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Nonalcoholic Steatohepatitis (NASH) market, by end-use.
Detailed analysis and profiles of additional market players.
<pre>Table of Contents Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2018 1 Nonalcoholic Steatohepatitis (NASH) Market Overview 1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH) 1.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type (Product Category) 1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Type (Product Category) in 2017 1.2.3 Weight Loss Treatment 1.2.3 Insulin-Sensitizing Agents 1.2.5 Lipid-Lowering Drugs 1.2.6 Antioxidants Other 1.3 Global Nonalcoholic Steatohepatitis (NASH) Segment by Application 1.3.1 Nonalcoholic Steatohepatitis (NASH) Consumption (Sales) Comparison by Application (2013-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Research Institute 1.3.5 Other 1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Region (2013-2025) 1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 1.4.2 North America Status and Prospect (2013-2025) 1.4.3 Europe Status and Prospect (2013-2025) 1.4.4 China Status and Prospect (2013-2025) 1.4.5 Japan Status and Prospect (2013-2025) 1.4.6 Southeast Asia Status and Prospect (2013-2025) 1.4.7 India Status and Prospect (2013-2025) 1.5 Global Market Size (Value) of Nonalcoholic Steatohepatitis (NASH) (2013-2025) 1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Status and Outlook (2013-2025) 1.5.2 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production Status and Outlook (2013-2025) 2 Global Nonalcoholic Steatohepatitis (NASH) Market Competition by Manufacturers 2.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production and Share by Manufacturers (2013-2018) 2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity and Share by Manufacturers (2013-2018) 2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Production and Share by Manufacturers (2013-2018) 2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufacturers (2013-2018) 2.3 Global Nonalcoholic Steatohepatitis (NASH) Average Price by Manufacturers (2013-2018) 2.4 Manufacturers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution, Sales Area and Product Type 2.5 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends 2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate 2.5.2 Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue (Value) by Region (2013-2018) 3.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity and Market Share by Region (2013-2018) 3.2 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Region (2013-2018) 3.3 Global Nonalcoholic Steatohepatitis (NASH) Revenue (Value) and Market Share by Region (2013-2018) 3.4 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.5 North America Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.6 Europe Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.7 China Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.8 Japan Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.9 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.10 India Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 4 Global Nonalcoholic Steatohepatitis (NASH) Supply (Production), Consumption, Export, Import by Region (2013-2018) 4.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption by Region (2013-2018) 4.2 North America Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 4.3 Europe Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 4.4 China Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 4.5 Japan Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 4.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 4.7 India Nonalcoholic Steatohepatitis (NASH) Production, Consumption, Export, Import (2013-2018) 5 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue (Value), Price Trend by Type 5.1 Global Nonalcoholic Steatohepatitis (NASH) Production and Market Share by Type (2013-2018) 5.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018) 5.3 Global Nonalcoholic Steatohepatitis (NASH) Price by Type (2013-2018) 5.4 Global Nonalcoholic Steatohepatitis (NASH) Production Growth by Type (2013-2018) 6 Global Nonalcoholic Steatohepatitis (NASH) Market Analysis by Application 6.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption and Market Share by Application (2013-2018) 6.2 Global Nonalcoholic Steatohepatitis (NASH) Consumption Growth Rate by Application (2013-2018) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries 7 Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Profiles/Analysis 7.1 Boehringer Ingelheim 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.1.4 Main Business/Business Overview 7.2 Cerenis Therapeutics 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.2.4 Main Business/Business Overview 7.3 Connexios Life Sciences 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.3.4 Main Business/Business Overview 7.4 Genfit 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Genfit Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.4.4 Main Business/Business Overview 7.5 Islet Sciences 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 7.5.4 Main Business/Business Overview 7.6 Nimbus Therapeutics 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.6.4 Main Business/Business Overview 7.7 Verva Pharmaceuticals 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.7.4 Main Business/Business Overview 7.8 Viking Therapeutics 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.8.4 Main Business/Business Overview 7.9 Astazeneca Plc 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.9.4 Main Business/Business Overview 7.8 Galmed Pharmaceuticals 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.10.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.10.4 Main Business/Business Overview 7.11 GENFIT SA 7.12 Gilead Science 7.13 Novo Nordisk 7.14 Immuron 7.15 Intercepts Pharmaceuticals 7.16 Enzo Biochem 7.17 Tobira Therapeutics 8 Nonalcoholic Steatohepatitis (NASH) Manufacturing Cost Analysis 8.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH) 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 9.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis 9.2 Upstream Raw Materials Sourcing 9.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017 9.4 Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Market Effect Factors Analysis 11.1 Technology Progress/Risk 11.1.1 Substitutes Threat 11.1.2 Technology Progress in Related Industry 11.2 Consumer Needs/Customer Preference Change 11.3 Economic/Political Environmental Change 12 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast (2018-2025) 12.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production, Revenue Forecast (2018-2025) 12.1.1 Global Nonalcoholic Steatohepatitis (NASH) Capacity, Production and Growth Rate Forecast (2018-2025) 12.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025) 12.1.3 Global Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2018-2025) 12.2 Global Nonalcoholic Steatohepatitis (NASH) Production, Consumption , Import and Export Forecast by Region (2018-2025) 12.2.1 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.3 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.4 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.6 India Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue and Price Forecast by Type (2018-2025) 12.4 Global Nonalcoholic Steatohepatitis (NASH) Consumption Forecast by Application (2018-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer</pre>


 Latest Research Reports